期刊文献+

待肾移植患者白细胞滤过输血的临床应用 被引量:3

Clinical Application of Transfusion of Leukocyte Filtering on Patients Waiting for Kidney Transplantation
在线阅读 下载PDF
导出
摘要 目的 探讨白细胞滤过输血对待肾移植患者产生HLA抗体的影响及巨细胞病毒 (CMV)感染率的降低程度。方法 选择 16 6例待肾移植患者进行临床输血观察 ,其中 92例进行白细胞滤过输血 ,74例进行浓缩红细胞输注。结果 白细胞滤过组 ,HLA抗体阳性率 1.1% ,巨细胞病毒感染率 3.2 % ;未滤过组HLA抗体阳性率 9.5 % ,巨细胞病毒感染率 13.5 % ;两者差别有高度显著性 (P <0 .0 1)。结论 白细胞滤除输血 ,能够有效预防HLA抗体产生 ,减少肾移植术后CMV感染 ,对确实需输血的待肾移植患者提供了一条安全有效的输血途径和措施。 Objective To investigate the effect of HLA-IgG and cytomegalovirus infection about transfusion of leukocyte filtering on the patients waiting for kidney transplantation. Methods A total of 166 patients waiting for kidney transplantation were divided into two groups, 92 cases were transfusion of leukocyte filtering, 74 cases were transfusion of concentrated red cells. Results In leukocyte filtering group,the HLA antibody positive rate 1.1%,the cytomtgalovirus infection rate is 3.2 %,the non-filtering group HLA antibody positive rate is 9.5%,the cytomegalovirus infection rate is 13.5%,there's obvious difference between them(P<0.01). Conclusion This method can effectively prevent HLA antibody production,lessen CMV infection.It was a security transfusion pathway to the patient waiting for kidney transplantation by transfusion of leukocyte filtering.
出处 《医药论坛杂志》 2004年第13期19-20,22,共3页 Journal of Medical Forum
关键词 输血 白细胞滤过 肾移植HLA抗体 巨细胞病毒感染 Transfusion Leukocyte filtering Kidney transplantation HLA antibodies CMV infection
  • 相关文献

参考文献2

共引文献3

同被引文献28

  • 1王长希,尚文俊,陈立中,费继光,邱江,郑克立.肾移植术的麻醉方式选择[J].实用医学杂志,2004,20(6):677-678. 被引量:18
  • 2Ledent E, Berlin G. Inadequate white cell reduction by bedside illtration of red cell concentrates [ J ]. Transfusion, 1994,34 ( 9 ) : 765-768.
  • 3Worthington JE, Thomas AA, Dyer PA, et al. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome[ J]. Transplantation, 1998,65 ( 1 ) : 121-125.
  • 4Horuk R, Colby TJ, Darbonne WC, et al. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor[ J]. Biochemistry, 1993,32 ( 22 ) :5733-5738.
  • 5Molina H,Holers VM,Li B,et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2 [ J ]. Proc Natl Acad Sci USA, 1996,93 (8) :3357-3361.
  • 6Humar A , Mazzulli T, Moussa G , et al. Clinical utility of cytomegalovirus (CMV)serology testing in high-risk CMV D+/R- transplant recipients[J]. Am J Transplant, 2005,5(5):1065-1070.
  • 7Piiparinen H , Helantera I , Lappalainen M, et al. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients[J]. J Med Virol, 2005,76 ( 3 ) :367-372.
  • 8Morales E , Andres A , Gonzalez E , et al. Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy[J] . Transplant Proc,2002,34( 1 ) :73-74.
  • 9Pass RF, Burke RL. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection[J] .Semin Pediatr Infect Dis , 2002 , 13 ( 3 ) : 196-204.
  • 10Berencsi K , Gyulai Z , Gonczol E , et al. A canarypox vector-expressing cytomegalovirus ( VMV ) phosphoprotein 65 induces long lasting cytotoxic T cell responses in human CMV-seronegative subjects[J]. J Infect Dis,2001,183 ( 8 ) :1171-1179.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部